Sector
PharmaceuticalsOpen
₹0.87Prev. Close
₹0.87Turnover(Lac.)
₹8.23Day's High
₹0.88Day's Low
₹0.8552 Week's High
₹1.4452 Week's Low
₹0.8Book Value
₹1.58Face Value
₹1Mkt Cap (₹ Cr.)
34.68P/E
87EPS
0.01Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 39.86 | 39.86 | 19.93 | 19.93 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 23.12 | 22.49 | 40.39 | 37.86 |
Net Worth | 62.98 | 62.35 | 60.32 | 57.79 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 17.21 | 2.47 | 7.85 | 8.53 |
yoy growth (%) | 596.07 | -68.52 | -7.95 | 302.84 |
Raw materials | -16.32 | -1.57 | -3.36 | -4.02 |
As % of sales | 94.86 | 63.69 | 42.82 | 47.1 |
Employee costs | -0.07 | -0.06 | -0.09 | -0.09 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 0.7 | 0.23 | 3.5 | 3.73 |
Depreciation | 0 | 0 | 0 | 0 |
Tax paid | -0.11 | 0 | 0 | 0 |
Working capital | -2.04 | 3.52 | 1.27 | 6.3 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 596.07 | -68.52 | -7.95 | 302.84 |
Op profit growth | 198.22 | -93.21 | -6.89 | 469.93 |
EBIT growth | 199.31 | -93.24 | -6.91 | 504.15 |
Net profit growth | 34.31 | -93.26 | -6.23 | 592.39 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Sombir Singh
Non Executive Director
Kishan Nityanand Naidu
Company Sec. & Compli. Officer
Namita Acharya
Independent Director
Harshadkumar Rathod
Chairman & Wholetime Director
Aman Patel
Non Executive Director
Amrutaben Solanki
Independent Director
Nimeshkumar Parmar
Independent Director
Harshadkumar Rathod
6 Flr Premises-602 Mahavir Apt,
2 Aushutosh Mukherjee Road,
West Bengal - 700020
Tel: -
Website: http://www.shreeganeshbiotech.com
Email: shreeganeshbiotechindialtd@gmail.com
D-511 Bagree Market,
5th Floor, 71 B R B Basu Road,
Kolkata - 700001
Tel: 91-033-22357270/7271
Website: www.nichetechpl.com
Email: nichetechpl@nichetechpl.com
Summary
Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as S.P. Commercial Co. Limited under the Registrar of Companies, West Bengal. The Company has got the Certificate of Commencem...
Read More
Reports by Shree Ganesh Biotech India Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.